Northwestern Mutual Wealth Management
AKTX

Northwestern Mutual Wealth Management’s Akari Therapeutics AKTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72 Buy
+7
New +$60 ﹤0.01% 4008

Other funds holding AKTX

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $673M AUM 55.24% 1-Year Est. Return

Northwestern Mutual Wealth Management's AKTX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Akari Therapeutics (AKTX) in Q2 2026: 7 shares worth $72. The stake represents ﹤0.01% of the portfolio and ranks #4008 among its holdings.

9 funds tracked by Wall St. Rank hold AKTX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 7 shares of Akari Therapeutics worth $72 as of Q2 2026.
  • Akari Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
  • Akari Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4008 holding.
  • 9 funds tracked by Wall St. Rank held Akari Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.